Paris named as Europe's leading tech ecosystem, beating London
STOCKHOLM: Paris has been named as the new
European tech champion
, beating London for the first time on some metrics, according to data from Dealroom, which collects information on startups and venture capital firms.
Between 2017 and 2024, the combined enterprise value of Paris startups increased 5.3 times, compared with 4.2 times for London, Dealroom said, after assessing dozens of metrics that contribute to a successful
tech ecosystem
.
Although London attracted bigger funding rounds, the actual valuations of the companies have not increased dramatically, while the funding rounds secured by Paris-based companies have had a bigger impact on valuations, it said.
French tech companies, including Mistral AI and Poolside, raised $7.8 billion last year, less than London's $11.3 billion.
Europe has been falling behind other regions in tech innovations, with only some countries trying to boost tech investments.
While the market capitalisation of global tech, media and telecom companies rose from $7 trillion in 2000 to $34 trillion last year, Europe's share dropped from 30% to just 7%, a McKinsey report said on Wednesday.
If Europe had maintained its share, it would have generated an additional $8 trillion in market value, it said.
Paris is also the only European city on Dealroom's top five global champions list, which is dominated by U.S. cities.
It comes a month ahead of Paris hosting one of the largest global tech conferences, VivaTech, featuring top executives from companies such as Nvidia, Alibaba, Meta , OpenAI, Mistral, Anthropic and Cohere. Last year's conference was attended by more than 165,000 people.
"It's not just about the competitiveness of Paris on the AI scene today, it's also about what will happen next and how we can keep on attracting the talent, investment, and the tech activities," Francois Bitouzet, managing director of VivaTech, told Reuters.
Since coming to power in 2017, French President Emmanuel Macron has talked about wanting France to be a world leader in AI and 'deep-tech', inviting several firms to invest in the country and pushing for creation of startup incubator Station F.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
34 minutes ago
- Business Standard
Beauty unicorn Good Glamm Group struggles to pay staff amid cash crunch
The Mumbai-based company has delayed employee salaries while seeking new funding, as three board directors from major VCs recently departed Bengaluru Listen to This Article Beauty unicorn Good Glamm Group is struggling to pay staff salaries amid a severe cash crunch that had prompted three board directors to exit, according to people familiar with the company's finances. 'There is no money in the bank and the company is not able to pay salaries to the employees,' said one person with direct knowledge of the situation. The firm is actively scouting for investors to raise around ₹200 crore to ₹250 crore to stay afloat. The financial crisis had led to the departure of three high-profile board members early this year. Anand Daniel, partner at Accel, Vishal
Indian Express
35 minutes ago
- Indian Express
Dubai eyes air taxi launch in 2026 after successful test flight
Dubai could soon transform daily commuting with the introduction of air taxis. California-based Joby Aviation successfully conducted the first test flight of its fully-electric aerial taxi in the emirate this week. The demonstration marks a critical step in Dubai's plan to integrate electric vertical takeoff and landing (eVTOL) aircraft into the city's mobility network by 2026. Joby Aviation aims to help ease the burden on Dubai's increasingly congested roads by offering a faster, eco-friendly alternative for short-distance travel. 'We want to change the way people commute,' Reuters quoted Anthony Khoury, Joby's UAE General Manager, as saying. According to the company, a trip from Dubai International Airport (DXB) to Palm Jumeirah using its aerial taxi will take just 12 minutes—compared to approximately 45 minutes by car. The future of cleaner, quieter urban travel just landed in Dubai. Today marks a significant milestone on our path to commercialization: we successfully completed a series of piloted, full-transition, electric vertical-takeoff-and-landing flights in — Joby Aviation (@jobyaviation) June 30, 2025 Earlier in 2024, Joby signed an exclusive six-year contract with Dubai's Roads and Transit Authority (RTA) to operate aerial taxis in the emirate. The commercial rollout, expected in 2026, will initially connect four vertiport hubs—Dubai International Airport, Palm Jumeirah, Dubai Downtown, and Dubai Marina. While affordability remains a long-term goal, Khoury acknowledged that the initial pricing structure may cater more to high-income travelers. 'As with any novel technology, early days might be a bit more premium,' he said. The test flight was held on Monday at a remote desert site southeast of Dubai's downtown. Designed to simulate a typical passenger route, the electric aircraft executed a vertical takeoff, flew several miles, and returned with a vertical landing. The event was attended by senior government officials, transport executives, and Joby Aviation representatives. The Joby Aerial Taxi is capable of flying up to 160 km at speeds reaching 320 kmph. With zero operating emissions, the fully-electric eVTOL is designed for minimal noise, making it ideal for urban use. 'It will be flying in the city, next to residential areas, and hopefully people will barely notice it,' Khoury noted. Despite the progress, the eVTOL industry still faces challenges such as regulatory approvals and infrastructure development, particularly the construction of vertiports. In April, Morgan Stanley downgraded Joby's stock price target from $10 to $7 due to execution risks and industry-wide concerns like supply-chain disruptions and tariffs. Joby shares currently trade at $10.55, according to Reuters.
Indian Express
40 minutes ago
- Indian Express
After probe report on financial irregularities, all but one clinical trials cancelled at Ahmedabad Hospital
When the investigation into the alleged financial irregularities in clinical trials at an Ahmedabad-based government hospital began, 10 trials were underway at the hospital while seven, for which agreements had been signed, were yet to begin. With the irregularities coming to light, all the clinical trials that were in their initial phases were shut down, while those that were yet to begin were cancelled, said a senior official of the Ahmedabad Municipal Corporation (AMC). As of now, only one clinical trial is underway at the Sheth Vadilal Sarabhai General Hospital, Medical Superintendent Dr Parul Shah confirmed with The Indian Express. Meanwhile, at least four to five doctors accused in the scam have returned the amount deposited in their bank accounts, said Dr Shah. 'We have sent the doctors notices that as per the report, we need to recover the money they received directly for the clinical trials. At least 4-5 doctors have already paid back the amount. The rest are also going to pay us back,' said Dr Shah. When asked if the hospital would conduct more trials in the coming days, an official said, 'We have decided to not do any clinical trials at the moment till all these irregularities are sorted out.' As reported by The Indian Express on July 1, a probe panel in Gujarat found financial irregularities in about 65 human clinical trials conducted at the hospital run by the AMC, where 15 doctors allegedly diverted at least Rs 1.87 crore directly to their personal accounts from 2021 — money that should have gone to the hospital first, according to a senior official. It has now also been learnt that the Drugs Controller General of India (DCGI) has asked the hospital not to conduct any more trials without proper standard operating procedures and permissions. The clinical trials that the hospital was conducting included those of drugs and formulations from 34 different pharmaceutical companies and clinical research companies (CROs), and were being managed by up to eight Site Management Organisations (SMOs). Of the 65 trials, a total of 48 had been completed, 10 were underway and seven were yet to begin, for which agreements had been signed. However, according to hospital officials, currently, only one trial is still underway. An official from the AMC Medical Education Trust (AMCMET) said, 'We had stopped most of the clinical trials that were in their initial phases before the investigation began. Only one trial is underway and we will complete that trial in the interest of the patients. No patients have had to suffer due to the financial irregularities.' Dr Shah said, 'The DCGI team that conducted its investigation here at the hospital said that the clinical trials themselves were conducted in a proper manner. Whatever discrepancies were there, were in the financial aspects. The trials were not compromised.' The DCGI, when it conducted its three-day investigation in May, asked the hospital to immediately stop the trials, form an ethics committee and get it vetted by the authorities if they wanted to conduct more trials, said sources. A total of 15 doctors were alleged to have siphoned off Rs 1.87 crore, proceeds from 58 clinical trials, into their personal bank accounts. Only Rs 10.63 lakh had been found to have been deposited in the account of the hospital. An inquiry committee found that a retired Medical Superintendent, an Associate Professor and 12 contractual doctors had been involved in the alleged scam
